Moon shot teams pursue innovative projects prioritized for greatest patient impact, including clinical trials of new cancer immunotherapies, targeted therapies and combinations. Collaborations heighten molecular understanding of cancers and therapies to further improve translational research and move scientific findings into the clinic. Many moon shots include prevention and early detection projects. Specialized platforms provide infrastructure, systems and strategy.
Ultimately, moon shot efforts will help support all cancer research at MD Anderson, particularly with improved resources and infrastructure. Funding is from private philanthropy, institutional earnings, competitive research grants and commercialization of new discoveries.
12 areas of focus:
- Acute myeloid leukemia/myelodysplastic syndromes
- B-cell lymphomas
- Chronic lymphocytic leukemia
- Colorectal cancer
- High-risk multiple myeloma
- Human papillomavirus-related cancers
- Lung cancer
- Pancreatic cancer
- Prostate cancer
- Triple negative breast and high-grade serous ovarian cancers
As of Dec. 31, private philanthropic commitments total more than $341.8 million.